Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTatton Asset Management Regulatory News (TAM)

Share Price Information for Tatton Asset Management (TAM)

Share Price is delayed by 15 minutes
Get Live Data
694.00    0.00 (0.00%)
Bid:
688.00
Ask:
690.00
Spread: 2.00 (0.291%)
Market Cap: £421.31m
TAM Live PriceLast checked at - London Stock Exchange

Intraday Tatton Asset Management Share Chart

First Day of Dealing

21 Jun 2007 07:00

Titanium Asset Management Corp 21 June 2007 Not for release, publication or distribution in, or into, the United States, Canada, Australia, Japan, the Republic of Ireland or South Africa Press Release June 21, 2007 Titanium Asset Management Corp. ('Titanium' or the 'Company') Successful completion of US$120,000,000 financing and first day of dealings Titanium Asset Management Corp., established to acquire companies engaged in the asset management industry, announces the admission of its common shares and warrants to trading on the AIM Market ('AIM') of the London Stock Exchange plc. Seymour Pierce Limited is acting as both Nominated Adviser and Broker to the Company. Sunrise Securities Corp. acted as Global Co-ordinator, Sole Bookrunner, Financial Adviser and Placing Agent. The trading symbols for the common shares and warrants are TAM.L and TAMW.L respectively. Titanium intends to acquire a number of specialists as well as multiproduct asset management firms with complementary investment strategies and strong investment performance which will then be managed as an integrated business. Titanium has already signed three Letters of Intent to acquire asset management businesses with combined assets under management of an estimated combined US$3.5bn. The acquisition strategy will initially focus on the US market, but will then be rolled out globally. Titanium has placed 20,000,000 units at US$6.00, each unit comprising one share and one warrant, raising US$120,000,000 before expenses. Clal Finance Ltd, an investment bank quoted on the Tel Aviv Stock Exchange, has acquired 10,100,000 units at the placing. A number of other major international institutional investors participated in the placing. Titanium has assembled a strong management team with extensive experience in the global asset management industry, led by Mr. John Kuzan as Chairman, Mr. John Sauickie as CEO and Mr. Nigel Wightman, Executive Director. Commentating on the placing Mr. Wightman, Executive Director, said: 'We are delighted to have the support of a strong shareholder group to pursue our business strategy. We believe that the global asset management industry will continue to grow significantly and we hope to acquire both specialist and multiproduct firms where we are able to expand the scale and scope of distribution to improve rates of asset accumulation.' Subject to compliance with applicable laws, stabilisation may be undertaken in relation to the shares during the period ending 20 July 2007 if the market price per share is less than $5.50. However stabilisation may cease at any time and there is no assurance that stabilisation will be undertaken. The manner in which the stabilisation will be undertaken is set out in the Company's admission document dated 18 June 2007. The common shares and warrants in the Company have not been registered under the U.S. Securities Act of 1933, as amended. The common shares and warrants may not be offered or sold within the U.S. or to U.S. persons, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Hedging transactions involving the Shares or Warrants may not be conducted unless in compliance with the Securities Act. For further information: Titanium Asset Management Corp Nigel Wightman, Executive Director Tel: +44 (0) 20 7822 1881 Seymour Pierce Limited Jonathan Wright, Director Tel: +44 (0) 20 7107 8000 Sunrise Securities Corp. Tel: (212) 421-1616 Dr. Amnon Mandelbaum, Senior Managing Director Penrose Financial Gay Collins Tel: +44 (0) 20 7786 4882 Mob: 07798626282 Julie Allison Tel: +44 (0) 20 7786 4872 Notes to editors: Clal Finance is Israel's largest publicly traded financial institution outside the banking system, providing a broad array of financial services, ranging from portfolio management to brokerage and underwriting services. It owns and operates mutual funds, an in-house hedge fund, and offers individually tailored structured products to clients. Clal Finance is owned 77% by Clal Insurance Enterprises Holdings and 23% by the public. Clal Insurance Enterprises Holdings is itself a publicly traded company in which IDB Development Corporation, one of Israel's largest holding companies, holds a 51% stake and Hapoalim Bank a 14% stake. THE INFORMATION CONTAINED HEREIN IS NOT FOR PUBLICATION OR DISTRIBUTION INTO THE UNITED STATES. THE MATERIAL SET FORTH HEREIN IS FOR INFORMATIONAL PURPOSES ONLY AND IS NOT INTENDED, AND SHOULD NOT BE CONSTRUED, AS AN OFFER OF SECURITIES FOR SALE INTO THE UNITED STATES OR ANY OTHER JURISDICTION. THE SECURITIES OF THE COMPANY DESCRIBED HEREIN HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE 'SECURITIES ACT'), OR THE LAWS OF ANY STATE, AND MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES, EXCEPT PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND APPLICABLE STATE LAWS. THERE IS NO INTENTION TO REGISTER ANY PORTION OF THE PLACING IN THE UNITED STATES OR TO CONDUCT A PUBLIC OFFERING OF SECURITIES IN THE UNITED STATES.
Date   Source Headline
17th Jun 202610:04 amRNSPDMR Dealing
16th Jun 20267:00 amRNSAudited Final Results
26th May 20267:00 amRNS-RNotice of Investor & Analyst Presentations
22nd May 20262:51 pmRNSHolding(s) in Company
21st May 202610:07 amRNSHolding(s) in Company
8th May 20264:47 pmRNSHolding(s) in Company
8th May 20262:19 pmRNSPDMR Dealing
7th May 202611:16 amRNSPDMR Dealing
27th Apr 20269:24 amRNSHolding(s) in Company
15th Apr 20267:00 amRNSTrading Update and Notice of Final Results
18th Mar 20267:00 amRNSPDMR Dealing
6th Mar 20267:00 amRNSPDMR Dealing
5th Mar 20267:00 amRNSExercise of Options and TVR
13th Feb 20268:58 amRNSPDMR Dealing
2nd Feb 20264:52 pmRNSBlock Listing Update
30th Jan 20269:11 amRNSPDMR Dealing
12th Dec 202512:47 pmRNSPDMR Dealing
10th Dec 20257:00 amRNSPurchase of Shares by EBT
28th Nov 20253:22 pmRNSShare purchase by a Non-Executive Director
18th Nov 20257:00 amRNSUnaudited Interim Results
28th Oct 20257:00 amRNS-RNotice of Investor & Analyst Presentations
17th Oct 202512:41 pmRNSPDMR Dealing
15th Oct 202510:56 amRNSExercise of Options, PDMR Dealing and TVR
14th Oct 20257:00 amRNSTrading Update and Notice of Results
5th Sep 20252:25 pmRNSPDMR Dealing
4th Sep 20253:14 pmRNSHolding(s) in Company
29th Aug 202510:30 amRNSOptions Exercise, PDMR Dealing, Block Listing, TVR
13th Aug 20254:03 pmRNSExercise of Options and TVR
12th Aug 20257:01 amRNSAppointment of Joint Broker
12th Aug 20257:00 amRNSRelated Party Transaction
24th Jul 20254:15 pmRNSResult of AGM
22nd Jul 202512:17 pmRNSExercise of Options, PDMR Dealing and TVR
14th Jul 20255:20 pmRNSHolding(s) in Company
10th Jul 20254:52 pmRNSHolding(s) in Company
9th Jul 202510:59 amRNSHolding(s) in Company
26th Jun 20251:56 pmRNSExercise of Options, PDMR Dealings and TVR
23rd Jun 20252:12 pmRNSNotice of AGM
16th Jun 202511:42 amRNSHolding(s) in Company
10th Jun 20257:00 amRNSFinal Results
13th May 20257:00 amRNS-RNotice of Investor & Analyst Presentations
15th Apr 20257:00 amRNSTrading Update and Notice of Chairman’s Retirement
28th Mar 20253:29 pmRNSDirector Appointment
14th Feb 20254:31 pmRNSPDMR Dealings
5th Feb 20254:37 pmRNSGrant of Options and PDMR Dealing
21st Jan 202510:31 amRNSExercise of Options and PDMR dealings
13th Nov 20247:00 amRNSUnaudited Interim Results
17th Oct 202411:52 amRNSHolding(s) in Company
15th Oct 20247:00 amRNSTrading Update and Notice of Results
23rd Aug 202412:10 pmRNSBlock Listing Application
8th Aug 20244:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.